FDA pilots ‘first-of-its-kind’ platform for sharing cancer trial PRO data

Written by Ilana Landau, Editor

The US FDA has announced its pilot launch of a ‘first-of-its-kind’, online platform to publicly communicate and share patient-reported outcome (PRO) and symptom data from cancer clinical trials of marketed therapeutics. The US FDA has announced its pilot launch of a ‘first-of-its-kind’, online platform – Project Patient Voice – to communicate and share patient-reported outcome (PRO) and symptom data from cancer clinical trials of marketed therapeutics with the public. The platform, an initiative of the FDA’s Oncology Center of Excellence, will represent the first time that patients and healthcare professionals will have access to these patient-reported data, which have historically...

To view the full article, please register now for access

It's completely free